Second Sight Medical Stock Fundamentals
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
Second Sight Medical fundamentals help investors to digest information that contributes to Second Sight's financial success or failures. It also enables traders to predict the movement of Second Stock. The fundamental analysis module provides a way to measure Second Sight's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Second Sight stock.
Second |
Second Sight Medical Company Shares Outstanding Analysis
Second Sight's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Second Sight Shares Outstanding | 39.41 M |
Most of Second Sight's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Second Sight Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Second Sight Medical has 39.41 M of shares currently outstending. This is 78.17% lower than that of the Healthcare sector and 77.47% lower than that of the Medical Devices industry. The shares outstanding for all United States stocks is 93.11% higher than that of the company.
Second Sight Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Second Sight's current stock value. Our valuation model uses many indicators to compare Second Sight value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Second Sight competition to find correlations between indicators driving Second Sight's intrinsic value. More Info.Second Sight Medical is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Second Sight by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Second Sight's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Second Sight's earnings, one of the primary drivers of an investment's value.Second Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Second Sight's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Second Sight could also be used in its relative valuation, which is a method of valuing Second Sight by comparing valuation metrics of similar companies.Second Sight is currently under evaluation in shares outstanding category among related companies.
Second Fundamentals
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 39.41 M | |||
| Shares Owned By Insiders | 28.61 % | |||
| Shares Owned By Institutions | 7.01 % | |||
| Number Of Shares Shorted | 1.19 M | |||
| Price To Earning | (1.61) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 616.54 X | |||
| Revenue | 497 K | |||
| Gross Profit | 130 K | |||
| EBITDA | (8.24 M) | |||
| Net Income | (8.29 M) | |||
| Cash And Equivalents | 59.6 M | |||
| Cash Per Share | 1.51 X | |||
| Total Debt | 199 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 25.25 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (10.38 M) | |||
| Short Ratio | 7.36 X | |||
| Earnings Per Share | (0.72) X | |||
| Number Of Employees | 15 | |||
| Beta | 2.76 | |||
| Market Capitalization | 163.15 M | |||
| Total Asset | 28.25 M | |||
| Retained Earnings | (328.85 M) | |||
| Working Capital | 18.78 M | |||
| Current Asset | 26.76 M | |||
| Current Liabilities | 7.98 M |
About Second Sight Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Second Sight Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Second Sight using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Second Sight Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. The company was founded in 1998 and is headquartered in Sylmar, California. Second Sight operates under Medical Devices classification in the United States and is traded on NAS Exchange. It employs 15 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Second Sight in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Second Sight's short interest history, or implied volatility extrapolated from Second Sight options trading.
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving together with Second Stock
| 0.78 | MDT | Medtronic PLC Financial Report 23rd of May 2024 | PairCorr |
Moving against Second Stock
| 0.76 | MDH | MDH Acquisition Corp | PairCorr |
| 0.73 | ARTE | Artemis Strategic | PairCorr |
| 0.62 | BSX | Boston Scientific Corp Buyout Trend | PairCorr |
| 0.5 | EW | Edwards Lifesciences Corp Earnings Call Today | PairCorr |
| 0.5 | DXCM | DexCom Inc Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |